Here's how LINK.SPRINGER.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

LINK . SPRINGER . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Link.springer.com Make Money
  6. Keywords
  7. Topics
  8. Schema
  9. External Links
  10. Analytics And Tracking
  11. Libraries

We are analyzing https://link.springer.com/article/10.1007/s10549-011-1889-0.

Title:
Phase 2 study of neoadjuvant treatment with NOV-002 in combination with doxorubicin and cyclophosphamide followed by docetaxel in patients with HER-2 negative clinical stage II–IIIc breast cancer | Breast Cancer Research and Treatment
Description:
NOV-002 (a formulation of disodium glutathione disulfide) modulates signaling pathways involved in tumor cell proliferation and metastasis and enhances anti-tumor immune responsiveness in tumor models. The addition of NOV-002 to chemotherapy has been shown to increase anti-tumor efficacy in animal models and some early phase oncology trials. We evaluated the clinical effects of NOV-002 in primary breast cancer, whether adding NOV-002 to standard preoperative chemotherapy increased pathologic complete response rates (pCR) at surgery, and determined whether NOV-002 mitigated hematologic toxicities of chemotherapy and whether levels of myeloid derived suppressor cells (MDSC) were predictive of response. Forty-one women with newly diagnosed stages II–IIIc HER-2 negative breast cancer received doxorubicin-cyclophosphamide followed by docetaxel (AC ā†’ T) every 3 weeks and concurrent daily NOV-002 injections. The trial was powered to detect a doubling of pCR rate from 16 to 32% with NOV-002 plus AC ā†’ T (α = 0.05, β = 80%). Weekly complete blood counts were obtained as well as circulating MDSC levels on day 1 of each cycle were quantified. Of 39 patients with 40 evaluable tumors, 15 achieved a pCR (38%), meeting the primary endpoint of the trial. Concurrent NOV-002 resulted in pCR rates for AC ā†’ T chemotherapy higher than previously reported. Patients with lower levels of circulating MDSCs at baseline and on the last cycle of chemotherapy had significantly higher probability of a pCR (P = 0.02). Further evaluation of NOV-002 in a randomized study is warranted.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {šŸ“š}

  • Health & Fitness
  • Education
  • Telecommunications

Content Management System {šŸ“}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {šŸ“ˆ}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 7,625,932 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {šŸ’ø}

We find it hard to spot revenue streams.

While many websites aim to make money, others are created to share knowledge or showcase creativity. People build websites for various reasons. This could be one of them. Link.springer.com might be earning cash quietly, but we haven't detected the monetization method.

Keywords {šŸ”}

cancer, article, google, scholar, pubmed, breast, cas, nov, chemotherapy, cell, oncol, response, cells, neoadjuvant, redox, clin, docetaxel, preoperative, patients, montero, glutathione, research, tumor, pathologic, treatment, doxorubicin, clinical, abstract, complete, suppressor, res, townsend, study, cyclophosphamide, pathways, therapy, privacy, cookies, content, journal, phase, diazmontero, signaling, primary, pcr, access, center, med, pazoles, tew,

Topics {āœ’ļø}

adjuvant anthracycline/taxane regimens myeloid-derived suppressor cells cancer tumor–node–metastasis stage month download article/chapter pathologic complete response redox-directed cancer therapeutics platinum-resistant ovarian cancer increase anti-tumor efficacy clinical cancer stage pathologic tumor response glutathione s-transferase p1–1 high-dose weekly schedule primary systemic therapy circulating mdsc levels redox-regulated transcription factors breast cancer cells ros-mediated mechanisms potentiates metastatic tumor burden early breast cancer glutathione disulfide-mimetic nov-002 operable breast cancer diaz-montero cm full article pdf breast cancer risk breast cancer subtypes hollings cancer center primary breast cancer privacy choices/manage cookies cancer cell death glutathione s-transferase related subjects unfolded protein response bowel project b-18 oncogenically transformed cells myeloid cells german breast group breast cancer outcome disodium glutathione disulfide tumor cell proliferation controlling tumor growth immune suppression mediated townsend dm check access modulating endogenous production instant access tumor cell invasion mitogenic signaling mediated glutathione disulfide mimetic cellular redox pathways ros-mediated mechanism

Schema {šŸ—ŗļø}

WebPage:
      mainEntity:
         headline:Phase 2 study of neoadjuvant treatment with NOV-002 in combination with doxorubicin and cyclophosphamide followed by docetaxel in patients with HER-2 negative clinical stage II–IIIc breast cancer
         description:NOV-002 (a formulation of disodium glutathione disulfide) modulates signaling pathways involved in tumor cell proliferation and metastasis and enhances anti-tumor immune responsiveness in tumor models. The addition of NOV-002 to chemotherapy has been shown to increase anti-tumor efficacy in animal models and some early phase oncology trials. We evaluated the clinical effects of NOV-002 in primary breast cancer, whether adding NOV-002 to standard preoperative chemotherapy increased pathologic complete response rates (pCR) at surgery, and determined whether NOV-002 mitigated hematologic toxicities of chemotherapy and whether levels of myeloid derived suppressor cells (MDSC) were predictive of response. Forty-one women with newly diagnosed stages II–IIIc HER-2 negative breast cancer received doxorubicin-cyclophosphamide followed by docetaxel (AC → T) every 3Ā weeks and concurrent daily NOV-002 injections. The trial was powered to detect a doubling of pCR rate from 16 to 32% with NOV-002 plus AC → T (α =Ā 0.05, β =Ā 80%). Weekly complete blood counts were obtained as well as circulating MDSC levels on day 1 of each cycle were quantified. Of 39 patients with 40 evaluable tumors, 15 achieved a pCR (38%), meeting the primary endpoint of the trial. Concurrent NOV-002 resulted in pCR rates for AC → T chemotherapy higher than previously reported. Patients with lower levels of circulating MDSCs at baseline and on the last cycle of chemotherapy had significantly higher probability of a pCR (PĀ =Ā 0.02). Further evaluation of NOV-002 in a randomized study is warranted.
         datePublished:2011-12-03T00:00:00Z
         dateModified:2011-12-03T00:00:00Z
         pageStart:215
         pageEnd:223
         sameAs:https://doi.org/10.1007/s10549-011-1889-0
         keywords:
            Breast cancer
            Neoadjuvant
            Phase 2
            NOV-002
            Glutathione analog
            MDSC
            Myeloid derived suppressor cells
            Pathologic complete response
            Anthracycline
            Taxane
            Oncology
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10549-011-1889-0/MediaObjects/10549_2011_1889_Fig1_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10549-011-1889-0/MediaObjects/10549_2011_1889_Fig2_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10549-011-1889-0/MediaObjects/10549_2011_1889_Fig3_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10549-011-1889-0/MediaObjects/10549_2011_1889_Fig4_HTML.gif
         isPartOf:
            name:Breast Cancer Research and Treatment
            issn:
               1573-7217
               0167-6806
            volumeNumber:132
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer US
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:A. J. Montero
               affiliation:
                     name:University of Miami
                     address:
                        name:Sylvester Comprehensive Cancer Center, University of Miami, Miami, USA
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:C. M. Diaz-Montero
               affiliation:
                     name:University of Miami
                     address:
                        name:Sylvester Comprehensive Cancer Center, University of Miami, Miami, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Y. E. Deutsch
               affiliation:
                     name:University of Miami
                     address:
                        name:Sylvester Comprehensive Cancer Center, University of Miami, Miami, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:J. Hurley
               affiliation:
                     name:University of Miami
                     address:
                        name:Sylvester Comprehensive Cancer Center, University of Miami, Miami, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:L. G. Koniaris
               affiliation:
                     name:Jefferson University Hospital
                     address:
                        name:Jefferson University Hospital, Philadelphia, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:T. Rumboldt
               affiliation:
                     name:Medical University of South Carolina
                     address:
                        name:Hollings Cancer Center, Medical University of South Carolina, Charleston, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:S. Yasir
               affiliation:
                     name:University of Miami
                     address:
                        name:Sylvester Comprehensive Cancer Center, University of Miami, Miami, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:M. Jorda
               affiliation:
                     name:University of Miami
                     address:
                        name:Sylvester Comprehensive Cancer Center, University of Miami, Miami, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:E. Garret-Mayer
               affiliation:
                     name:Medical University of South Carolina
                     address:
                        name:Hollings Cancer Center, Medical University of South Carolina, Charleston, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:E. Avisar
               affiliation:
                     name:University of Miami
                     address:
                        name:Sylvester Comprehensive Cancer Center, University of Miami, Miami, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:J. Slingerland
               affiliation:
                     name:University of Miami
                     address:
                        name:Sylvester Comprehensive Cancer Center, University of Miami, Miami, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:O. Silva
               affiliation:
                     name:University of Miami
                     address:
                        name:Sylvester Comprehensive Cancer Center, University of Miami, Miami, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:C. Welsh
               affiliation:
                     name:University of Miami
                     address:
                        name:Sylvester Comprehensive Cancer Center, University of Miami, Miami, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:K. Schuhwerk
               affiliation:
                     name:Novelos Therapeutics Inc.
                     address:
                        name:Novelos Therapeutics Inc., Newton, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:P. Seo
               affiliation:
                     name:University of Miami
                     address:
                        name:Sylvester Comprehensive Cancer Center, University of Miami, Miami, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:M. D. Pegram
               affiliation:
                     name:University of Miami
                     address:
                        name:Sylvester Comprehensive Cancer Center, University of Miami, Miami, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:S. Glück
               affiliation:
                     name:University of Miami
                     address:
                        name:Sylvester Comprehensive Cancer Center, University of Miami, Miami, USA
                        type:PostalAddress
                     type:Organization
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Phase 2 study of neoadjuvant treatment with NOV-002 in combination with doxorubicin and cyclophosphamide followed by docetaxel in patients with HER-2 negative clinical stage II–IIIc breast cancer
      description:NOV-002 (a formulation of disodium glutathione disulfide) modulates signaling pathways involved in tumor cell proliferation and metastasis and enhances anti-tumor immune responsiveness in tumor models. The addition of NOV-002 to chemotherapy has been shown to increase anti-tumor efficacy in animal models and some early phase oncology trials. We evaluated the clinical effects of NOV-002 in primary breast cancer, whether adding NOV-002 to standard preoperative chemotherapy increased pathologic complete response rates (pCR) at surgery, and determined whether NOV-002 mitigated hematologic toxicities of chemotherapy and whether levels of myeloid derived suppressor cells (MDSC) were predictive of response. Forty-one women with newly diagnosed stages II–IIIc HER-2 negative breast cancer received doxorubicin-cyclophosphamide followed by docetaxel (AC → T) every 3Ā weeks and concurrent daily NOV-002 injections. The trial was powered to detect a doubling of pCR rate from 16 to 32% with NOV-002 plus AC → T (α =Ā 0.05, β =Ā 80%). Weekly complete blood counts were obtained as well as circulating MDSC levels on day 1 of each cycle were quantified. Of 39 patients with 40 evaluable tumors, 15 achieved a pCR (38%), meeting the primary endpoint of the trial. Concurrent NOV-002 resulted in pCR rates for AC → T chemotherapy higher than previously reported. Patients with lower levels of circulating MDSCs at baseline and on the last cycle of chemotherapy had significantly higher probability of a pCR (PĀ =Ā 0.02). Further evaluation of NOV-002 in a randomized study is warranted.
      datePublished:2011-12-03T00:00:00Z
      dateModified:2011-12-03T00:00:00Z
      pageStart:215
      pageEnd:223
      sameAs:https://doi.org/10.1007/s10549-011-1889-0
      keywords:
         Breast cancer
         Neoadjuvant
         Phase 2
         NOV-002
         Glutathione analog
         MDSC
         Myeloid derived suppressor cells
         Pathologic complete response
         Anthracycline
         Taxane
         Oncology
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10549-011-1889-0/MediaObjects/10549_2011_1889_Fig1_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10549-011-1889-0/MediaObjects/10549_2011_1889_Fig2_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10549-011-1889-0/MediaObjects/10549_2011_1889_Fig3_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10549-011-1889-0/MediaObjects/10549_2011_1889_Fig4_HTML.gif
      isPartOf:
         name:Breast Cancer Research and Treatment
         issn:
            1573-7217
            0167-6806
         volumeNumber:132
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer US
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:A. J. Montero
            affiliation:
                  name:University of Miami
                  address:
                     name:Sylvester Comprehensive Cancer Center, University of Miami, Miami, USA
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:C. M. Diaz-Montero
            affiliation:
                  name:University of Miami
                  address:
                     name:Sylvester Comprehensive Cancer Center, University of Miami, Miami, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Y. E. Deutsch
            affiliation:
                  name:University of Miami
                  address:
                     name:Sylvester Comprehensive Cancer Center, University of Miami, Miami, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:J. Hurley
            affiliation:
                  name:University of Miami
                  address:
                     name:Sylvester Comprehensive Cancer Center, University of Miami, Miami, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:L. G. Koniaris
            affiliation:
                  name:Jefferson University Hospital
                  address:
                     name:Jefferson University Hospital, Philadelphia, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:T. Rumboldt
            affiliation:
                  name:Medical University of South Carolina
                  address:
                     name:Hollings Cancer Center, Medical University of South Carolina, Charleston, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:S. Yasir
            affiliation:
                  name:University of Miami
                  address:
                     name:Sylvester Comprehensive Cancer Center, University of Miami, Miami, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:M. Jorda
            affiliation:
                  name:University of Miami
                  address:
                     name:Sylvester Comprehensive Cancer Center, University of Miami, Miami, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:E. Garret-Mayer
            affiliation:
                  name:Medical University of South Carolina
                  address:
                     name:Hollings Cancer Center, Medical University of South Carolina, Charleston, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:E. Avisar
            affiliation:
                  name:University of Miami
                  address:
                     name:Sylvester Comprehensive Cancer Center, University of Miami, Miami, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:J. Slingerland
            affiliation:
                  name:University of Miami
                  address:
                     name:Sylvester Comprehensive Cancer Center, University of Miami, Miami, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:O. Silva
            affiliation:
                  name:University of Miami
                  address:
                     name:Sylvester Comprehensive Cancer Center, University of Miami, Miami, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:C. Welsh
            affiliation:
                  name:University of Miami
                  address:
                     name:Sylvester Comprehensive Cancer Center, University of Miami, Miami, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:K. Schuhwerk
            affiliation:
                  name:Novelos Therapeutics Inc.
                  address:
                     name:Novelos Therapeutics Inc., Newton, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:P. Seo
            affiliation:
                  name:University of Miami
                  address:
                     name:Sylvester Comprehensive Cancer Center, University of Miami, Miami, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:M. D. Pegram
            affiliation:
                  name:University of Miami
                  address:
                     name:Sylvester Comprehensive Cancer Center, University of Miami, Miami, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:S. Glück
            affiliation:
                  name:University of Miami
                  address:
                     name:Sylvester Comprehensive Cancer Center, University of Miami, Miami, USA
                     type:PostalAddress
                  type:Organization
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Breast Cancer Research and Treatment
      issn:
         1573-7217
         0167-6806
      volumeNumber:132
Organization:
      name:Springer US
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:University of Miami
      address:
         name:Sylvester Comprehensive Cancer Center, University of Miami, Miami, USA
         type:PostalAddress
      name:University of Miami
      address:
         name:Sylvester Comprehensive Cancer Center, University of Miami, Miami, USA
         type:PostalAddress
      name:University of Miami
      address:
         name:Sylvester Comprehensive Cancer Center, University of Miami, Miami, USA
         type:PostalAddress
      name:University of Miami
      address:
         name:Sylvester Comprehensive Cancer Center, University of Miami, Miami, USA
         type:PostalAddress
      name:Jefferson University Hospital
      address:
         name:Jefferson University Hospital, Philadelphia, USA
         type:PostalAddress
      name:Medical University of South Carolina
      address:
         name:Hollings Cancer Center, Medical University of South Carolina, Charleston, USA
         type:PostalAddress
      name:University of Miami
      address:
         name:Sylvester Comprehensive Cancer Center, University of Miami, Miami, USA
         type:PostalAddress
      name:University of Miami
      address:
         name:Sylvester Comprehensive Cancer Center, University of Miami, Miami, USA
         type:PostalAddress
      name:Medical University of South Carolina
      address:
         name:Hollings Cancer Center, Medical University of South Carolina, Charleston, USA
         type:PostalAddress
      name:University of Miami
      address:
         name:Sylvester Comprehensive Cancer Center, University of Miami, Miami, USA
         type:PostalAddress
      name:University of Miami
      address:
         name:Sylvester Comprehensive Cancer Center, University of Miami, Miami, USA
         type:PostalAddress
      name:University of Miami
      address:
         name:Sylvester Comprehensive Cancer Center, University of Miami, Miami, USA
         type:PostalAddress
      name:University of Miami
      address:
         name:Sylvester Comprehensive Cancer Center, University of Miami, Miami, USA
         type:PostalAddress
      name:Novelos Therapeutics Inc.
      address:
         name:Novelos Therapeutics Inc., Newton, USA
         type:PostalAddress
      name:University of Miami
      address:
         name:Sylvester Comprehensive Cancer Center, University of Miami, Miami, USA
         type:PostalAddress
      name:University of Miami
      address:
         name:Sylvester Comprehensive Cancer Center, University of Miami, Miami, USA
         type:PostalAddress
      name:University of Miami
      address:
         name:Sylvester Comprehensive Cancer Center, University of Miami, Miami, USA
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:A. J. Montero
      affiliation:
            name:University of Miami
            address:
               name:Sylvester Comprehensive Cancer Center, University of Miami, Miami, USA
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:C. M. Diaz-Montero
      affiliation:
            name:University of Miami
            address:
               name:Sylvester Comprehensive Cancer Center, University of Miami, Miami, USA
               type:PostalAddress
            type:Organization
      name:Y. E. Deutsch
      affiliation:
            name:University of Miami
            address:
               name:Sylvester Comprehensive Cancer Center, University of Miami, Miami, USA
               type:PostalAddress
            type:Organization
      name:J. Hurley
      affiliation:
            name:University of Miami
            address:
               name:Sylvester Comprehensive Cancer Center, University of Miami, Miami, USA
               type:PostalAddress
            type:Organization
      name:L. G. Koniaris
      affiliation:
            name:Jefferson University Hospital
            address:
               name:Jefferson University Hospital, Philadelphia, USA
               type:PostalAddress
            type:Organization
      name:T. Rumboldt
      affiliation:
            name:Medical University of South Carolina
            address:
               name:Hollings Cancer Center, Medical University of South Carolina, Charleston, USA
               type:PostalAddress
            type:Organization
      name:S. Yasir
      affiliation:
            name:University of Miami
            address:
               name:Sylvester Comprehensive Cancer Center, University of Miami, Miami, USA
               type:PostalAddress
            type:Organization
      name:M. Jorda
      affiliation:
            name:University of Miami
            address:
               name:Sylvester Comprehensive Cancer Center, University of Miami, Miami, USA
               type:PostalAddress
            type:Organization
      name:E. Garret-Mayer
      affiliation:
            name:Medical University of South Carolina
            address:
               name:Hollings Cancer Center, Medical University of South Carolina, Charleston, USA
               type:PostalAddress
            type:Organization
      name:E. Avisar
      affiliation:
            name:University of Miami
            address:
               name:Sylvester Comprehensive Cancer Center, University of Miami, Miami, USA
               type:PostalAddress
            type:Organization
      name:J. Slingerland
      affiliation:
            name:University of Miami
            address:
               name:Sylvester Comprehensive Cancer Center, University of Miami, Miami, USA
               type:PostalAddress
            type:Organization
      name:O. Silva
      affiliation:
            name:University of Miami
            address:
               name:Sylvester Comprehensive Cancer Center, University of Miami, Miami, USA
               type:PostalAddress
            type:Organization
      name:C. Welsh
      affiliation:
            name:University of Miami
            address:
               name:Sylvester Comprehensive Cancer Center, University of Miami, Miami, USA
               type:PostalAddress
            type:Organization
      name:K. Schuhwerk
      affiliation:
            name:Novelos Therapeutics Inc.
            address:
               name:Novelos Therapeutics Inc., Newton, USA
               type:PostalAddress
            type:Organization
      name:P. Seo
      affiliation:
            name:University of Miami
            address:
               name:Sylvester Comprehensive Cancer Center, University of Miami, Miami, USA
               type:PostalAddress
            type:Organization
      name:M. D. Pegram
      affiliation:
            name:University of Miami
            address:
               name:Sylvester Comprehensive Cancer Center, University of Miami, Miami, USA
               type:PostalAddress
            type:Organization
      name:S. Glück
      affiliation:
            name:University of Miami
            address:
               name:Sylvester Comprehensive Cancer Center, University of Miami, Miami, USA
               type:PostalAddress
            type:Organization
PostalAddress:
      name:Sylvester Comprehensive Cancer Center, University of Miami, Miami, USA
      name:Sylvester Comprehensive Cancer Center, University of Miami, Miami, USA
      name:Sylvester Comprehensive Cancer Center, University of Miami, Miami, USA
      name:Sylvester Comprehensive Cancer Center, University of Miami, Miami, USA
      name:Jefferson University Hospital, Philadelphia, USA
      name:Hollings Cancer Center, Medical University of South Carolina, Charleston, USA
      name:Sylvester Comprehensive Cancer Center, University of Miami, Miami, USA
      name:Sylvester Comprehensive Cancer Center, University of Miami, Miami, USA
      name:Hollings Cancer Center, Medical University of South Carolina, Charleston, USA
      name:Sylvester Comprehensive Cancer Center, University of Miami, Miami, USA
      name:Sylvester Comprehensive Cancer Center, University of Miami, Miami, USA
      name:Sylvester Comprehensive Cancer Center, University of Miami, Miami, USA
      name:Sylvester Comprehensive Cancer Center, University of Miami, Miami, USA
      name:Novelos Therapeutics Inc., Newton, USA
      name:Sylvester Comprehensive Cancer Center, University of Miami, Miami, USA
      name:Sylvester Comprehensive Cancer Center, University of Miami, Miami, USA
      name:Sylvester Comprehensive Cancer Center, University of Miami, Miami, USA
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {šŸ”—}(180)

Analytics and Tracking {šŸ“Š}

  • Google Tag Manager

Libraries {šŸ“š}

  • Clipboard.js
  • Prism.js

6.47s.